Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PAREXEL International Corp (NASDAQ:PRXL)

59.19
Delayed Data
As of 11:51am ET
 +0.45 / +0.77%
Today’s Change
51.16
Today|||52-Week Range
71.13
-13.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$3.1B

Company Description

PAREXEL International Corp. engages in the provision of clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries. It operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics. The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affairs, patient recruitment and investigator site services. The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting. The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes. The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Contact Information

PAREXEL International Corp.
195 West Street
Waltham Massachusetts 02451
P:(781) 487-9900
Investor Relations:

Employees

Shareholders

Mutual fund holders51.87%
Other institutional47.98%
Individual stakeholders3.05%

Top Executives

Josef H. von RickenbachChairman & Chief Executive Officer
Mark A. GoldbergPresident & Chief Operating Officer
Emma ReeveCFO, Principal Accounting Officer, VP & Controller
Sy PretoriusChief Scientific Officer & Vice President
Joseph C. AvelloneExecutive Vice President